Takeda Pharmaceutical Company Limited Asset Turnover Ratio (TAK), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Takeda Pharmaceutical Company Limited  (NYSE: TAK)
 

Takeda Pharmaceutical Limited Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Takeda Pharmaceutical Company Limited asset turnover ratio, the ability of Takeda Pharmaceutical Company Limited's assets to generate revenue in the first quarter 2026, increased sequentially to 0.47 in the first quarter (Jun 30 2026), yet the ratio remained below the average, as TAK's position remain challenging.

Within sector 84 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2026 compared to the preceding quarter from to 2232.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TAK Asset Turnover Ratio (Jun 30 2026)
I. Quarter		 (Mar 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Asset Change -25.44 % -12.18 % 6.88 % -12.18 % -9.14 %
Y / Y Revenue Change - 0.06 % - -1.19 % -
Asset Turnover Ratio (TTM) 0.47 0.36 - 0.35 -
TAK's Total Ranking # 2232 # # # #
Seq. Asset Change 6.58 % -12.18 % 13.88 % -30.04 % 25.53 %
Seq. Revenue Change -73.77 % - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 85
Healthcare Sector # 290
Overall Market # 2232

Asset Turnover Ratio Statistics
High Average Low
6.68 5.54 4.26
(Mar 31 2024)   (Mar 31 2021)




TAK Company Profile • Back to TAK Efficiency Comparisons • Compare TAK Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Warby Parker Inc   1.24 $ 912.542  Millions$ 734.141  Millions
Electromed Inc   1.24 $ 72.076  Millions$ 58.289  Millions
Myomo Inc   1.22 $ 44.242  Millions$ 36.202  Millions
Rockwell Medical inc   1.22 $ 69.827  Millions$ 57.145  Millions
Ardent Health Inc   1.22 $ 6,405.940  Millions$ 5,244.371  Millions
Docgo Inc   1.22 $ 294.721  Millions$ 241.732  Millions
Xtant Medical Holdings Inc   1.21 $ 108.748  Millions$ 89.533  Millions
Henry Schein Inc   1.21 $ 13,602.000  Millions$ 11,249.250  Millions
Inogen Inc   1.20 $ 354.304  Millions$ 294.283  Millions
Sanuwave Health Inc   1.20 $ 43.903  Millions$ 36.661  Millions
Nuwellis Inc   1.19 $ 9.013  Millions$ 7.547  Millions
The Pennant Group Inc   1.19 $ 1,101.710  Millions$ 928.899  Millions
Angiodynamics Inc   1.18 $ 317.726  Millions$ 268.407  Millions
Tela Bio Inc   1.18 $ 80.535  Millions$ 68.159  Millions
Liquidia Corporation  1.18 $ 450.907  Millions$ 381.842  Millions
Myriad Genetics Inc   1.17 $ 805.900  Millions$ 686.825  Millions
Precision Optics Corporation Inc   1.17 $ 31.532  Millions$ 27.049  Millions
Universal Health Services Inc   1.16 $ 18,114.487  Millions$ 15,622.036  Millions
Polomar Health Services, Inc.  1.15 $ 3.172  Millions$ 2.748  Millions
Puma Biotechnology Inc   1.15 $ 231.244  Millions$ 201.150  Millions
Sunshine Biopharma Inc   1.15 $ 35.347  Millions$ 30.782  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  1.15 $ 25.185  Millions$ 21.950  Millions
Natera Inc   1.14 $ 2,707.077  Millions$ 2,372.930  Millions
Elite Pharmaceuticals Inc   1.14 $ 140.130  Millions$ 122.899  Millions
Neuronetics Inc   1.14 $ 154.594  Millions$ 135.996  Millions
Mettler toledo International Inc   1.13 $ 4,133.875  Millions$ 3,643.493  Millions
Mimedx Group Inc   1.13 $ 354.086  Millions$ 312.829  Millions
Harvard Bioscience Inc   1.13 $ 88.164  Millions$ 78.072  Millions
Pro dex Inc   1.13 $ 77.548  Millions$ 68.744  Millions
Biodesix Inc   1.12 $ 102.939  Millions$ 91.540  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.